Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  ex vivo-expanded HER2-specific T cells
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
HER2-Specific T Cells in Treating Patients With HER2-Positive Refractory or Metastatic Sarcoma
Status: Active
Phase: Phase I
Type: Treatment
Age: Not specified
Trial IDs: HEROS, NCI-2012-00634, NCT00902044
Start Over